Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-19-060084

Director acquired 100,503 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DIGIANDOMENICO ANTHONY · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-12-11 Grant or award : show line 1 in the form +100,503 $0.87 $87,438 199,226 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-12-11 Grant or award : show line 2 in the form Stock option (right to buy) +89,585 89,585 D
2019-12-11 Grant or award : show line 3 in the form Warrants +100,503 100,503 D
Loading xslF345X03/doc4.xml…